Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Malvern Reports on the Publication of the 1000th Peer-reviewed Paper to Cite NanoSight’s NTA

Published: Wednesday, April 16, 2014
Last Updated: Tuesday, April 15, 2014
Bookmark and Share
Nanoparticle Tracking Analysis made measuring size easier and more accurate.

Malvern Instruments reports on the publication of the 1000th peer-reviewed paper to cite the company’s NanoSight Nanoparticle Tracking Analysis, NTA. Entitled “Fumed Silica Nanoparticle Mediated Biomimicry for Optimal Cell-Material Interactions for Artificial Organ Development,” it was authored by the research team of Professor Alexander Seifalian from University College London.

Alexander Seifalian is Professor of Nanotechnology and Regenerative Medicine at UCL Centre for Nanotechnology and Regenerative Medicine within the Division of Surgery and Interventional Science at University College London, UK. His research focus is on the development of human organs using nano composite materials and stem cells as well as treatment of cancer using nanoparticles.

With nanoparticles requiring rapid and repeatable measurement, Professor Seifalian selected Malvern’s NanoSight Nanoparticle Tracking Analysis (NTA) system. Previous to this, he had used techniques including scanning electron microscopy (SEM) and atomic force microscopy (AFM) but found that NTA made measuring size easier and more accurate.

Professor Seifalian’s paper, "Fumed Silica Nanoparticle Mediated Biomimicry for Optimal Cell-Material Interactions for Artificial Organ Development” published in the Journal of Macromolecular Biosciences (WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim), was the 1000th peer-reviewed item to be published where results from NTA are cited. In the paper, a fumed silica nanoparticle mediated procedure of scaffold functionalization is described which can be potentially adapted with multiple bioactive molecules to induce cellular biomimicry in the development of human organs. The proposed nanocomposite materials are already in patient use for implants including the world’s first synthetic trachea, tear ducts and coronary and vascular bypass grafts.

Nanoparticle Tracking Analysis detects and visualizes populations of nanoparticles in liquids down to 10 nm, dependent on material, and measures the size of each particle from direct observations of diffusion. Additionally, NTA measures concentration while a fluorescence mode differentiates suitably-labelled particles within complex background suspensions.

This real-time data gives insight into the kinetics of protein aggregation and other time-dependent phenomena in a qualitative and quantitative manner. NTA has a growing role in biodiagnostics, being proven in detection and speciation of extracellular vesicles.

NanoSight NTA systems are part of Malvern’s extensive portfolio of solutions for the characterization of nanomaterials.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

First Time at Pittcon for new Malvern Systems
Malvern is exhibiting its particle characterization and rheology ranges at Pittcon 2006.
Thursday, January 05, 2006
Scientific News
New Biomarker to Assess Stem Cells Developed
A research team led by scientists from UCL have found a way to assess the viability of 'manufactured' stem cells known as induced pluripotent stem cells (iPSCs). The team's discovery offers a new way to fast-track screening methods used in stem cell research.
A Better Model for Parkinson's
Scientists at EPFL solve a longstanding problem with modeling Parkinson’s disease in animals. Using newfound insights, they improve both cell and animal models for the disease, which can propel research and drug development.
Faster Drug Discovery?
Startup develops more cost-effective test for assessing how cells respond to chemicals.
Microalgae Make a Splash in the UK Cosmeceutical Market
Scottish innovators have discovered an anti-viral and anti-inflammatory carbohydrate in microscopic algae (microalgae) which has huge potential to change the cosmetics market.
Mechanism of Tumor Suppressing Gene Uncovered
The most commonly mutated gene in cancer,p53, works to prevent tumor formation by keeping mobile elements in check that otherwise lead to genomic instability, UT Southwestern Medical Center researchers have found.
Experimental Combination Surprises with Anti-HIV Effectiveness
A compound developed to protect the nervous system from HIV surprised researchers by augmenting the effectiveness of an investigational antiretroviral drug beyond anything expected.
Useful Colon Cancer Biomarker Discovered
Biomarker is detectable with simple, inexpensive test.
A New Type of Anticancer Agent
Success in the development of a ?-tubulin specific inhibitor.
Seeing Hope
Gene therapy/drug combo restores some vision in mice with optic nerve injury.
Versatile New Molecule-Building Technique
Chemists at The Scripps Research Institute (TSRI) have devised a new and widely applicable technique for building potential drug molecules and other organic compounds.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!